View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/FDA | RIN: 0910-AG44 | Publication ID: Spring 2011 |
| Title: Antimicrobial Active Ingredient Distribution Reports Under Section 105 of the Animal Drug User Fee Amendments of 2008 | |
| Abstract: Section 105 of the Animal Drug User Fee Amendments of 2008 (ADUFA) amended section 512 of the Federal Food, Drug, and Cosmetic Act (the Act) (21 U.S.C. 360b) to require that the sponsor of each new animal drug that contains an antimicrobial agent submit an annual report to the Food and Drug Administration on the amount of each antimicrobial active ingredient in the drug that is sold or distributed for use in food-producing animals, including information on any distributor-labeled product. FDA recognizes the need for standardized reporting; thus, this direct final rule, with its companion proposal, is to mandate the use of an FDA form. | |
| Agency: Department of Health and Human Services(HHS) | Priority: Info./Admin./Other |
| RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Completed Actions |
| Major: No | Unfunded Mandates: No |
| CFR Citation: 21 CFR 514.80 | |
| Legal Authority: 21 USC 360b(l)(3) | |
|
Legal Deadline:
None |
||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: Undetermined | Government Levels Affected: None |
| Small Entities Affected: Businesses | Federalism: No |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Lee D. Korb Regulatory Counsel Department of Health and Human Services Food and Drug Administration Suite 3037 (HFD-7), Center for Veterinary Medicine, 7519 Standish Place, Room 164, MPN-4, HFV-200, Rockville, MD 20855 Phone:240 276-9258 Fax:240 276-7692 Email: lee.korb@fda.hhs.gov |
|
An official website of the United States government



